|
Whole blood FOLH1 mRNA expression and treatment response in metastatic castration-resistant prostate cancer (mCRPC). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Ipsen; Novartis |
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme (Inst); Pfizer |
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Ipsen; MSD |
Research Funding - Clinical Genomics |
Travel, Accommodations, Expenses - Amgen; Roche |
|
|
Travel, Accommodations, Expenses - Astellas Pharma |
|
|
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Eisai (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche/Genentech (Inst) |
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research. |
|
|
No Relationships to Disclose |
|
|
Honoraria - Ipsen; Janssen |
Consulting or Advisory Role - Ferring; Pfizer |
Travel, Accommodations, Expenses - Amgen; Astellas Pharma |
|
|
Employment - Connected Medical Solutions (I) |
Leadership - Connected Medical Solutions (I) |
Stock and Other Ownership Interests - Connected Medical Solutions (I) |
Research Funding - Astellas Pharma |
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag |
|
|
Honoraria - Amgen; Astellas Pharma; Janssen; Novartis; Pfizer; Tolmar |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Sanofi; Tolmar |
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Novartis |
Research Funding - Astellas Pharma |
Travel, Accommodations, Expenses - Astellas Pharma; Sanofi |